Mary Kay has patented a method for reducing melanin in hyperpigmented skin by topically applying a composition containing specific plant extracts. The method aims to reduce the appearance of hyperpigmented skin caused by increased melanin production. GlobalData’s report on Mary Kay gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Mary Kay, Nanoemulsion cosmetics was a key innovation area identified from patents. Mary Kay's grant share as of January 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11883523B2) discloses a method for reducing melanin in hyperpigmented skin caused by increased melanin production. The method involves topically applying a composition containing a mixture of Ptychopetalum olacoides bark/stem extract, Pfaffia paniculata root extract, and Trichilia catigua bark extract, all obtained by aqueous extraction. The composition, ranging from 0.0001 wt. % to 1 wt. % of the mixture, has shown efficacy in reducing melanin in hyperpigmented skin, potentially addressing conditions like senile lentigo or melasma.
Furthermore, the composition not only reduces melanin but also has the potential to whiten the skin, even out skin tone, and decrease melanogenesis activity through the activation of an adiponectin receptor, specifically PAQR7. The mixture, which may also contain water, butylene glycol, and PEG-40 hydrogenated castor oil, is formulated in concentrations ranging from 0.0001 to 0.5% w/w. The versatility of the composition is highlighted by its formulation as an emulsion or gel, offering different application options for individuals seeking to address hyperpigmentation concerns effectively. This patent provides a novel approach to skincare by targeting melanin reduction through a specific combination of natural extracts, potentially offering a promising solution for individuals dealing with hyperpigmented skin conditions.
To know more about GlobalData’s detailed insights on Mary Kay, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
